CIK 0001314052 · Large accelerated filer<br>Smaller reporting company
ANAVEX LIFE SCIENCES CORP.
Sign in to watch- Ticker
- AVXL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Entity type
- operating
- EIN
- 980608404
- Phone
- 844-689-3939
- Business address
- 630 5TH AVENUE, 20TH FLOOR, NEW YORK, NY, 10111
- Former names
- Thrifty Printing Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-28 | Boenisch Sandra PFO & Treasurer | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2025-04-28 | MISSLING CHRISTOPHER U President and CEO | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-03-31 | Donhauser Peter D.O. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-03-31 | Ma Jiong Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-03-31 | Skarpelos Athanasios Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-03-31 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-03-31 | Velden Claus Vander Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-03-24 | MISSLING CHRISTOPHER U President and CEO | Option exercise | +500,000 | $0.92 | $460K | 1,750,210 |
| 2025-03-24 | MISSLING CHRISTOPHER U President and CEO | Shares withheld for taxes | −282,497 | $9.63 | $2.7M | 1,467,713 |
| 2025-03-24 | MISSLING CHRISTOPHER U President and CEO | Option exercise · Stock Option (Right to Buy) | −500,000 | 0 | ||
| 2025-01-15 | MISSLING CHRISTOPHER U President and CEO | Grant or award · Stock Option (Right to Buy) | +166,666 | 166,000 | ||
| 2025-01-15 | MISSLING CHRISTOPHER U President and CEO | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-01-15 | Boenisch Sandra PFO & Treasurer | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-12-19 | Boenisch Sandra PFO & Treasurer | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-12-19 | MISSLING CHRISTOPHER U President and CEO | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2024-11-19 | MISSLING CHRISTOPHER U President and CEO | Grant or award · Stock Option (Right to Buy) | +125,000 | 250,000 | ||
| 2024-11-19 | Boenisch Sandra PFO & Treasurer | Grant or award · Stock Option (Right to Buy) | +10,000 | 20,000 | ||
| 2024-06-14 | Donhauser Peter D.O. Director | Purchase | +2,835 | $3.64 | $10K | 5,000 |
| 2024-05-15 | Thomas Steffen Director | Purchase | +5,000 | $4.52 | $23K | 5,000 |
| 2024-03-28 | MISSLING CHRISTOPHER U President and CEO | Option exercise | +73,380 | $1.32 | $97K | 1,323,590 |
Page 2 of 12 · 232 trades